Literature DB >> 28620096

Interleukin-6 Family Cytokines.

Stefan Rose-John1.   

Abstract

The interleukin (IL)-6 family cytokines is a group of cytokines consisting of IL-6, IL-11, ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), oncostatin M (OSM), cardiotrophin 1 (CT-1), cardiotrophin-like cytokine (CLC), and IL-27. They are grouped into one family because the receptor complex of each cytokine contains two (IL-6 and IL-11) or one molecule (all others cytokines) of the signaling receptor subunit gp130. IL-6 family cytokines have overlapping but also distinct biologic activities and are involved among others in the regulation of the hepatic acute phase reaction, in B-cell stimulation, in the regulation of the balance between regulatory and effector T cells, in metabolic regulation, and in many neural functions. Blockade of IL-6 family cytokines has been shown to be beneficial in autoimmune diseases, but bacterial infections and metabolic side effects have been observed. Recent advances in cytokine blockade might help to minimize such side effects during therapeutic blockade.
Copyright © 2018 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28620096      PMCID: PMC5793756          DOI: 10.1101/cshperspect.a028415

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  125 in total

1.  Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130.

Authors:  Mari A Nowell; Peter J Richards; Sankichi Horiuchi; Naoki Yamamoto; Stefan Rose-John; Nicholas Topley; Anwen S Williams; Simon A Jones
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

2.  Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist.

Authors:  Erwan Mortier; Jérôme Bernard; Ariane Plet; Yannick Jacques
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

Review 3.  Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization.

Authors:  Jan Suthaus; Nina Adam; Joachim Grötzinger; Jürgen Scheller; Stefan Rose-John
Journal:  Eur J Cell Biol       Date:  2010-12-21       Impact factor: 4.492

4.  Adult mice with targeted mutation of the interleukin-11 receptor (IL11Ra) display normal hematopoiesis.

Authors:  H H Nandurkar; L Robb; D Tarlinton; L Barnett; F Köntgen; C G Begley
Journal:  Blood       Date:  1997-09-15       Impact factor: 22.113

5.  IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality.

Authors:  Hong Zhang; Patrick Neuhöfer; Liang Song; Björn Rabe; Marina Lesina; Magdalena U Kurkowski; Matthias Treiber; Thomas Wartmann; Sara Regnér; Henrik Thorlacius; Dieter Saur; Gregor Weirich; Akihiko Yoshimura; Walter Halangk; Joseph P Mizgerd; Roland M Schmid; Stefan Rose-John; Hana Algül
Journal:  J Clin Invest       Date:  2013-02-15       Impact factor: 14.808

6.  Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor.

Authors:  J Müllberg; H Schooltink; T Stoyan; P C Heinrich; S Rose-John
Journal:  Biochem Biophys Res Commun       Date:  1992-12-15       Impact factor: 3.575

7.  Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice.

Authors:  Stacey R Dillon; Cindy Sprecher; Angela Hammond; Janine Bilsborough; Maryland Rosenfeld-Franklin; Scott R Presnell; Harald S Haugen; Mark Maurer; Brandon Harder; Janet Johnston; Susan Bort; Sherri Mudri; Joseph L Kuijper; Tom Bukowski; Pamela Shea; Dennis L Dong; Maria Dasovich; Francis J Grant; Luann Lockwood; Steven D Levin; Cosette LeCiel; Kim Waggie; Heather Day; Stavros Topouzis; Janet Kramer; Rolf Kuestner; Zhi Chen; Don Foster; Julia Parrish-Novak; Jane A Gross
Journal:  Nat Immunol       Date:  2004-06-06       Impact factor: 25.606

8.  Therapeutic targeting of interleukin-6 trans-signaling does not affect the outcome of experimental tuberculosis.

Authors:  Jan Sodenkamp; Georg H Waetzig; Jürgen Scheller; Dirk Seegert; Joachim Grötzinger; Stefan Rose-John; Stefan Ehlers; Christoph Hölscher
Journal:  Immunobiology       Date:  2012-01-20       Impact factor: 3.144

9.  Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines.

Authors:  A Zilberstein; R Ruggieri; J H Korn; M Revel
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

10.  Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130.

Authors:  D P Gearing; C J Thut; T VandeBos; S D Gimpel; P B Delaney; J King; V Price; D Cosman; M P Beckmann
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

View more
  155 in total

1.  Engineering a potent receptor superagonist or antagonist from a novel IL-6 family cytokine ligand.

Authors:  Jun W Kim; Cesar P Marquez; R Andres Parra Sperberg; Jiaxiang Wu; Won G Bae; Po-Ssu Huang; E Alejandro Sweet-Cordero; Jennifer R Cochran
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-10       Impact factor: 11.205

2.  The regulation of skeletal muscle fatigability and mitochondrial function by chronically elevated interleukin-6.

Authors:  Brandon N VanderVeen; Dennis K Fix; Ryan N Montalvo; Brittany R Counts; Ashley J Smuder; E Angela Murphy; Ho-Jin Koh; James A Carson
Journal:  Exp Physiol       Date:  2019-01-15       Impact factor: 2.969

3.  Knockout of the neonatal Fc receptor in cultured podocytes alters IL-6 signaling and the actin cytoskeleton.

Authors:  Pantipa Tonsawan; James Dylewski; Linda Lewis; Judith Blaine
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-25       Impact factor: 4.249

4.  Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses.

Authors:  Stephan Wilmes; Polly-Anne Jeffrey; Jonathan Martinez-Fabregas; Maximillian Hafer; Paul K Fyfe; Elizabeth Pohler; Silvia Gaggero; Martín López-García; Grant Lythe; Charles Taylor; Thomas Guerrier; David Launay; Suman Mitra; Jacob Piehler; Carmen Molina-París; Ignacio Moraga
Journal:  Elife       Date:  2021-04-19       Impact factor: 8.140

Review 5.  Salivary Inflammatory Molecules as Biomarkers of Sleep Alterations: A Scoping Review.

Authors:  Vanessa Ibáñez-Del Valle; Rut Navarro-Martínez; Maria Luisa Ballestar-Tarin; Omar Cauli
Journal:  Diagnostics (Basel)       Date:  2021-02-10

Review 6.  JAK/STAT signaling in stem cells and regeneration: from Drosophila to vertebrates.

Authors:  Salvador C Herrera; Erika A Bach
Journal:  Development       Date:  2019-01-29       Impact factor: 6.868

7.  Endothelial signaling by neutrophil-released oncostatin M enhances P-selectin-dependent inflammation and thrombosis.

Authors:  Hendra Setiadi; Tadayuki Yago; Zhenghui Liu; Rodger P McEver
Journal:  Blood Adv       Date:  2019-01-22

8.  The ERK signaling pathway is involved in cardiotrophin-1-induced neural differentiation of human umbilical cord blood mesenchymal stem cells in vitro.

Authors:  Changhui Lang; Xiaomei Shu; Longying Peng; Xiaohua Yu
Journal:  Cytotechnology       Date:  2019-09-05       Impact factor: 2.058

9.  Oncostatin M and its role in fibrosis.

Authors:  Lukasz Stawski; Maria Trojanowska
Journal:  Connect Tissue Res       Date:  2018-07-30       Impact factor: 3.417

Review 10.  Can mesenchymal stem cells be used to treat COVID-19-induced pneumonia? (Review).

Authors:  İdil Çetin; Mehmet Topçul
Journal:  Biomed Rep       Date:  2020-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.